M27.62 (ICD 10 CM) Post-osseointegration biological failure of dental implant
Conditions
Interventions
Group 1: IIT
In peri-implant sites with mucositis CHX (chlorhexidine) gel is applied in the control group (GC) at baseline and after three months. At baseline and after six months, peri-implant pocket
Sponsors
Clinic of Preventive Dentistry, Periodontology and Cariology
Eligibility
Sex/Gender
All
Age
18 Years to 110 Years
Inclusion criteria
Inclusion criteria: • Adult women and men (=18 y) • Informed consent as documented by signature • Systemically healthy subjects • At least one dental implant loaded by fixed single crowns or bridges (screwed or cemented) with mucositis in terms of a probing pocket depth between 3 an 5 and bleeding on probing • Bone loss = 2mm as detectable on X-ray • Ability to read and understand the patient information
Exclusion criteria
Exclusion criteria: • Patients with active periodontal pockets • Pregnant or nursing women or women planning to have a child • Patients with antibiotic therapy within the previous 6 months • Patients with peri-implantitis therapy within the previous 3 months • Subjects with an allergy to CHX • Heavy smokers (=10 cigarettes per day) • Anti-coagulated patients (exception: =100 mg/d acetylsalicylic acid) • Removable prostheses attached on the affected implants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Manual assessment of peri-implant pocket depths with a periodontal probe after 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessemnt of bleeding-on-probing and aMMP-8 levels after 6 months | — |
Countries
Switzerland
Contacts
Public ContactPatrick Schmidlin
Zentrum für ZahnmedizinUniversität Zürich
Outcome results
None listed